Aldeyra Therapeutics logo

Aldeyra Therapeutics Share Price Today

(NASDAQ: ALDX)

Aldeyra Therapeutics share price is $6.19 & ₹538.34 as on 6 Mar 2025, 2.30 'hrs' IST

$6.19

0.02

(0.32%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Aldeyra Therapeutics share price in Dollar and Rupees. Guide to invest in Aldeyra Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Aldeyra Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Aldeyra Therapeutics share price movements

  • Today's Low: $5.85
    Today's High: $6.27

    Day's Volatility :6.67%

  • 52 Weeks Low: $2.71
    52 Weeks High: $6.92

    52 Weeks Volatility :60.84%

Aldeyra Therapeutics (ALDX) Returns

PeriodAldeyra Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
24.65%
2.1%
0.0%
6 Months
-2.37%
-4.1%
0.0%
1 Year
57.0%
2.2%
0.0%
3 Years
64.53%
11.8%
-11.6%

Aldeyra Therapeutics (ALDX) Key Statistics

in dollars & INR

Previous Close
$6.17
Open
$6.19
Today's High
$6.27
Today's Low
$5.852
Market Capitalization
$360.9M
Today's Volume
$121.3K
52 Week High
$6.92
52 Week Low
$2.71
Revenue TTM
$0.0
EBITDA
$-59.9M
Earnings Per Share (EPS)
$-0.75
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-58.55%

How to invest in Aldeyra Therapeutics Stock (ALDX) from India?

It is very easy for Indian residents to invest directly in Aldeyra Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aldeyra Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aldeyra Therapeutics or ALDX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aldeyra Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aldeyra Therapeutics shares which would translate to 0.140 fractional shares of Aldeyra Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Aldeyra Therapeutics, in just a few clicks!

Returns in Aldeyra Therapeutics (ALDX) for Indian investors in Rupees

The Aldeyra Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aldeyra Therapeutics investment value today

Current value as on today

₹1,62,469

Returns

₹62,469

(+62.47%)

Returns from Aldeyra Therapeutics Stock

₹57,506 (+57.51%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Aldeyra Therapeutics (ALDX)

-48%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Aldeyra Therapeutics Stock from India on INDmoney has decreased by -48% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Aldeyra Therapeutics

  • Perceptive Advisors LLC

    15.58%

  • Knoll Capital Management LP

    9.19%

  • BlackRock Inc

    6.36%

  • Vanguard Group Inc

    6.31%

  • Kennedy Capital Management Inc

    2.47%

  • Ardsley Advisory Partners

    1.93%

Analyst Recommendation on Aldeyra Therapeutics

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Aldeyra Therapeutics(by analysts ranked 0 to 5 stars)

Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
11
11
Hold
1
2
2
Sell
0
0
0

Analyst Forecast on Aldeyra Therapeutics Stock (ALDX)

What analysts predicted

Upside of 61.55%

Target:

$10.00

Current:

$6.19

Insights on Aldeyra Therapeutics Stock (Ticker Symbol: ALDX)

  • Price Movement

    In the last 1 month, ALDX stock has moved up by 8.1%
  • ALDX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 5.3%

Aldeyra Therapeutics Technicals Summary

Sell

Neutral

Buy

Aldeyra Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Aldeyra Therapeutics (ALDX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Aldeyra Therapeutics Inc logo
19.34%
-2.37%
57.0%
64.53%
107.05%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Aldeyra Therapeutics Inc logo
NA
NA
0.0
-0.6
-0.59
-0.3
NA
1.19
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Aldeyra Therapeutics Inc logo
Buy
$360.9M
107.05%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Aldeyra Therapeutics

Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases. The company also develops ADX-629, an orally administered RASP modulator for treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment retinitis pigmentosa, as well as rare retinal diseases characterized by inflammation and vision loss. In addition, it develops ADX-246 in systemic immune-mediated disease; and ADX-248 in geographic atrophy. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.
Organization
Aldeyra Therapeutics
Employees
0
CEO
Dr. Todd C. Brady M.D., Ph.D.
Industry
Health Technology

Management People of Aldeyra Therapeutics

NameTitle
Dr. Todd C. Brady M.D., Ph.D.
CEO, President & Director
David Burke
Head of Investor Relations
Laura Nichols
Operations Manager

Important FAQs about investing in ALDX Stock from India :

What is Aldeyra Therapeutics share price today?

Aldeyra Therapeutics share price today stands at $6.19, Open: $6.19 ; Previous Close: $6.17 ; High: $6.27 ; Low: $5.85 ; 52 Week High: $6.92 ; 52 Week Low: $2.71.

The stock opens at $6.19, after a previous close of $6.17. The stock reached a daily high of $6.27 and a low of $5.85, with a 52-week high of $6.92 and a 52-week low of $2.71.

Can Indians buy Aldeyra Therapeutics shares?

Yes, Indians can invest in the Aldeyra Therapeutics (ALDX) from India.

With INDmoney, you can buy Aldeyra Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Aldeyra Therapeutics at zero transaction cost.

How can I buy Aldeyra Therapeutics shares from India?

It is very easy to buy Aldeyra Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aldeyra Therapeutics (ALDX) be purchased?

Yes, you can buy fractional shares of Aldeyra Therapeutics with INDmoney app.

What are the documents required to start investing in Aldeyra Therapeutics stocks?

To start investing in Aldeyra Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Aldeyra Therapeutics Stock (ALDX)?

Today’s highest price of Aldeyra Therapeutics (ALDX) is $6.27.

Today’s lowest price of Aldeyra Therapeutics (ALDX) is $5.85.

What is today's market capitalisation of Aldeyra Therapeutics?

Today's market capitalisation of Aldeyra Therapeutics ALDX is 360.9M

What is the 52 Week High and Low Range of Aldeyra Therapeutics Stock (ALDX)?

  • 52 Week High

    $6.92

  • 52 Week Low

    $2.71

What are the historical returns of Aldeyra Therapeutics (ALDX)?

  • 1 Month Returns

    19.34%

  • 3 Months Returns

    -2.37%

  • 1 Year Returns

    57%

  • 5 Years Returns

    107.05%

Who is the Chief Executive Officer (CEO) of Aldeyra Therapeutics ?

Dr. Todd C. Brady M.D., Ph.D. is the current Chief Executive Officer (CEO) of Aldeyra Therapeutics.